Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04276493
Brief Title: Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab

First Submitted : February 4, 2020
First Submitted that Met QC Criteria : February 18, 2020
First Posted : February 19, 2020

Last Update Submitted that Met QC Criteria : May 25, 2021
Last Update Posted : May 26, 2021